Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

906.71 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,219
Open 906.71
Bid (Size) 909.04 (1)
Ask (Size) 911.00 (1)
Prev. Close 906.71
Today's Range 906.71 - 906.71
52wk Range 434.34 - 916.83
Shares Outstanding N/A
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These 4 Vanguard ETFs Soared Over 20% in the First Half of 2024. Here's Which One Is Most Likely to Fly Even Higher.
These Vanguard ETFs have a lot in common. 
Via The Motley Fool
Topics ETFs
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
The treatment is intended for adults in the early symptomatic stages of Alzheimer's disease. 
Via Benzinga
Exposures Product Safety

Performance

YTD
+53.11%
+53.11%
1 Month
+9.08%
+9.08%
3 Month
+18.69%
+18.69%
6 Month
+53.11%
+53.11%
1 Year
+96.50%
+96.50%

More News

Read More
Eli Lilly Receives FDA Approval For Its Alzheimer’s Drug Kinsula
Via Talk Markets
Exposures Product Safety
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
Via Benzinga
AMZN Stock Outlook: Amazon’s Next Growth Wave Could Make Early Investors Rich
Via InvestorPlace
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
Via Investor's Business Daily
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
Via The Motley Fool
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
Via Benzinga
Topics Economy
Exposures Interest Rates
Novo, Lilly Dive After Biden Slams Duo For 'Unconscionably High' Drug Prices
Via Investor's Business Daily
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Via MarketBeat
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Via Benzinga
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Via MarketBeat
Exposures Product Safety
Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Via Benzinga
Is Google Stock A Buy With Earnings Due, New CFO Waiting In The Wings?
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
Via The Motley Fool
2 Top Healthcare Stocks to Buy in June
Via The Motley Fool
Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
Via InvestorPlace
This Is Massive News for Eli Lilly Investors
Via The Motley Fool
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
Via InvestorPlace
Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
First Half 2024 -- That's A Wrap
Via Talk Markets
Topics ETFs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.